ACEA, a highly selective CB1R agonist, was reported to provide a neuroprotective effect for ischemic stroke, Parkinson's disease, Alzheimer's disease, and epilepsy [29, 41, 42, 44]. Here, CNR1 is linked to Parkinson disease.